Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
CORV was delisted on the 26th of May, 2020.
36 hedge funds and large institutions have $41.6M invested in Correvio Pharma Corp. Ordinary Shares (Canada) in 2019 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 16 increasing their positions, 11 reducing their positions, and 5 closing their positions.
45% more repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 11
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
10% less funds holding
Funds holding: 40 → 36 (-4)
28% less capital invested
Capital invested by funds: $58.2M → $41.6M (-$16.6M)
80% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 5
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $199K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TA
Tamarack Advisers
Carlsbad,
California
|
+$2.43M |
| 2 |
RA
Royce & Associates
New York
|
+$372K |
| 3 |
AIP
ARS Investment Partners
New York
|
+$215K |
| 4 |
LPL Financial
San Diego,
California
|
+$104K |
| 5 |
Westfield Capital Management
Boston,
Massachusetts
|
+$95.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CPA
Columbia Pacific Advisors
Seattle,
Washington
|
-$413K |
| 2 |
SR
Summer Road
West Palm Beach,
Florida
|
-$383K |
| 3 |
WVP
Worth Venture Partners
Fort Lee,
New Jersey
|
-$217K |
| 4 |
PI
Putnam Investments
Boston,
Massachusetts
|
-$203K |
| 5 |
Renaissance Technologies
New York
|
-$136K |
CORV Hedge Fund Activity: Q2 2019 in Review
36 of the 4,625 institutional investors tracked by Wall St. Rank reported a position in Correvio Pharma Corp. Ordinary Shares (Canada) (CORV) for Q2 2019, worth a combined $41.6M — down 28% from $58.2M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of CORV and 1 opened new positions — a net loss of 4 holders — while 11 trimmed existing stakes and 16 added.
The largest buyer was Tamarack Advisers, adding an estimated $2.43M. The largest seller was Columbia Pacific Advisors, exiting entirely with an estimated $413K sold.
- 36 institutional investors held Correvio Pharma Corp. Ordinary Shares (Canada) (CORV) as of Q2 2019, down from 40 in Q1 2019.
- Funds reported $41.6M of Correvio Pharma Corp. Ordinary Shares (Canada) stock for Q2 2019, down 28% quarter-over-quarter.
- 1 fund opened new Correvio Pharma Corp. Ordinary Shares (Canada) positions in Q2 2019 and 5 closed out, a net change of -4 holders.
- The largest Correvio Pharma Corp. Ordinary Shares (Canada) buyer in Q2 2019 was Tamarack Advisers, an estimated $2.43M added.
- The largest Correvio Pharma Corp. Ordinary Shares (Canada) seller in Q2 2019 was Columbia Pacific Advisors, an estimated $413K sold.
Based on aggregated 13F filings for Q2 2019.